RxSight, Inc.
RXST
$25.84
$0.622.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 35.29% | 48.95% | 55.96% | 31.12% | 41.21% |
| Total Depreciation and Amortization | -51.75% | 0.97% | -20.39% | 14.11% | 12.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 57.55% | 2.47% | 55.73% | 61.23% | 21.07% |
| Change in Net Operating Assets | -11.32% | 418.43% | -216.05% | 39.91% | -75.63% |
| Cash from Operations | 48.68% | 108.14% | 46.63% | 47.60% | 40.08% |
| Capital Expenditure | 46.76% | -68.91% | 16.46% | -163.32% | -339.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.80% | -145.50% | -1,935.35% | 155.11% | -42.82% |
| Cash from Investing | -71.09% | -153.60% | -2,731.29% | 150.19% | -56.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 64.71% | 99.95% | 99.97% | 34.15% | 12.82% |
| Issuance of Common Stock | -16.63% | -72.47% | 396.88% | -84.60% | -46.02% |
| Repurchase of Common Stock | 100.00% | -143.08% | -- | -533.23% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 70.21% | 71.38% | -- | 104.78% |
| Cash from Financing | -16.45% | 110.66% | 12,411.00% | -87.76% | -43.52% |
| Foreign Exchange rate Adjustments | -250.00% | 240.00% | -200.00% | -250.00% | -42.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.46% | -832.23% | -262.99% | 2,892.46% | -105.78% |
